ALMS vs RARE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 24, 2026

ALMS

36.7
AI Score
VS
RARE Wins

RARE

39.8
AI Score

Investment Advisor Scores

ALMS

37score
Recommendation
AVOID NEW MONEY

RARE

40score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric ALMS RARE Winner
Forward P/E 0 0 Tie
PEG Ratio 0 -0.24 Tie
Revenue Growth -37.7% 28.1% RARE
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 36.7/100 39.8/100 RARE
Profit Margin 0.0% -81.7% ALMS
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

ALMS 1M: -7.0% · 3M: -75.0% RARE 1M: +6.0% · 3M: -41.8%

Current Technical Phase

ALMS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -41.5%), weak momentum, RSI 34

RSI (14): 33.6 · Price: $6.78

RARE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.4 · Price: $15.65

Fundamentals Snapshot

Metric ALMS RARE
Market Cap — —
Forward P/E -2.4 69.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.4% 0.3%
Gross Margin 1.0% -0.2%
Operating Margin -64.4% -0.4%
EPS -3.86 -5.82
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, RARE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.